This approach allowed us to identify the PI3K/AKT/mTORC1 activation in skin-resident SS cells, a pathway already found altered in CTCL by others [21, 22], that we also analyzed at the genomic and biochemical level in SS cell lines and primary tumor cells. This evidence concerns the gene AKT1 and synovial sarcoma.